Literature DB >> 10896703

Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS?

C Oppenheim1, D Galanaud, Y Samson, M Sahel, D Dormont, B Wechsler, C Marsault.   

Abstract

The precise mechanism of neurological symptoms in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is still controversial. The diffusion weighted MR findings at the acute phase of a neurological event in MELAS are described and the pathophysiology of stroke-like lesion in the light of diffusion changes is discussed. Brain MRI was performed 2 days after the sudden onset of cortical blindness in a 25 year old patient with MELAS. Fluid attenuated inversion recovery (FLAIR) images showed multifocal cortical and subcortical hyperintensities located bilaterally in the frontobasal and the temporo-occipital lobes. Diffusion weighted images showed normal to increased apparent diffusion coefficient values in the acute left temporooccipital lesion and increased values in the older stroke-like lesions. These diffusion weighted findings support the metabolic rather than the ischaemic pathophysiological hypothesis for stroke-like episodes occurring in MELAS. Normal or increased apparent diffusion coefficient values within 48 hours of a neurological deficit of abrupt onset should raise the possibility of MELAS, especially if conventional MR images show infarct-like lesions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896703      PMCID: PMC1737057          DOI: 10.1136/jnnp.69.2.248

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

1.  MR diffusion tensor imaging, fiber tracking, and single-voxel spectroscopy findings in an unusual MELAS case.

Authors:  Denis Ducreux; Ghaidaa Nasser; Catherine Lacroix; David Adams; Pierre Lasjaunias
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

2.  MRI and diffusion-weighted imaging followup of a stroke-like event in a patient with MELAS.

Authors:  S Stoquart-Elsankari; P Lehmann; B Périn; C Gondry-Jouet; O Godefroy
Journal:  J Neurol       Date:  2008-07-28       Impact factor: 4.849

Review 3.  The neuro-ophthalmology of mitochondrial disease.

Authors:  J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal:  Surv Ophthalmol       Date:  2010-05-14       Impact factor: 6.048

Review 4.  Laboratory approach to mitochondrial diseases.

Authors:  D Parra; A González; C Mugueta; A Martínez; I Monreal
Journal:  J Physiol Biochem       Date:  2001-09       Impact factor: 4.158

5.  Apparent diffusion coefficients of metabolites in patients with MELAS using diffusion-weighted MR spectroscopy.

Authors:  Z Liu; D Zheng; X Wang; J Zhang; S Xie; J Xiao; X Jiang
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-24       Impact factor: 3.825

Review 6.  Cerebral imaging in paediatric mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuroradiol J       Date:  2018-07-06

7.  Mitochondrial encephalomyopathy: comparison of conventional MR imaging with diffusion-weighted and diffusion tensor imaging: case report.

Authors:  Charles B Majoie; Erik M Akkerman; Christian Blank; Peter G Barth; Bwee Tien Poll-The; G J den Heeten
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

Review 8.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

9.  Comparison of conventional and diffusion-weighted MRI and proton MR spectroscopy in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like events.

Authors:  K Abe; H Yoshimura; H Tanaka; N Fujita; T Hikita; S Sakoda
Journal:  Neuroradiology       Date:  2003-12-12       Impact factor: 2.804

10.  Serial diffusion-weighted imaging in a patient with MELAS and presumed cytotoxic oedema.

Authors:  X Y Wang; K Noguchi; S Takashima; N Hayashi; S Ogawa; H Seto
Journal:  Neuroradiology       Date:  2003-07-25       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.